Epidemiologic features and clinical course of patients infected with SARS-CoV-2 in Singapore BE Young, SWX Ong, S Kalimuddin, JG Low, SY Tan, J Loh, OT Ng, ... Jama 323 (15), 1488-1494, 2020 | 2506 | 2020 |
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls N Le Bert, AT Tan, K Kunasegaran, CYL Tham, M Hafezi, A Chia, ... Nature 584 (7821), 457-462, 2020 | 2046 | 2020 |
Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients AT Tan, M Linster, CW Tan, N Le Bert, WN Chia, K Kunasegaran, ... Cell reports 34 (6), 2021 | 641 | 2021 |
Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study WN Chia, F Zhu, SWX Ong, BE Young, SW Fong, N Le Bert, CW Tan, ... The Lancet Microbe 2 (6), e240-e249, 2021 | 372 | 2021 |
Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19) CW Tan, LP Ho, S Kalimuddin, BPZ Cherng, YE Teh, SY Thien, HM Wong, ... Nutrition 79, 111017, 2020 | 367 | 2020 |
Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection N Le Bert, HE Clapham, AT Tan, WN Chia, CYL Tham, JM Lim, ... Journal of Experimental Medicine 218 (5), e20202617, 2021 | 310 | 2021 |
Decision tree algorithms predict the diagnosis and outcome of dengue fever in the early phase of illness L Tanner, M Schreiber, JGH Low, A Ong, T Tolfvenstam, YL Lai, LC Ng, ... PLoS neglected tropical diseases 2 (3), e196, 2008 | 309 | 2008 |
A dynamic immune response shapes COVID-19 progression EZ Ong, YFZ Chan, WY Leong, NMY Lee, S Kalimuddin, SMH Mohideen, ... Cell host & microbe 27 (6), 879-882. e2, 2020 | 306 | 2020 |
Nebulized Colistin in the Treatment of Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii and Pseudomonas aeruginosa ALH Kwa, CS Loh, JGH Low, A Kurup, VH Tam Clinical infectious diseases 41 (5), 754-757, 2005 | 248 | 2005 |
Efficacy and safety of celgosivir in patients with dengue fever (CELADEN): a phase 1b, randomised, double-blind, placebo-controlled, proof-of-concept trial JG Low, C Sung, L Wijaya, Y Wei, APS Rathore, S Watanabe, BH Tan, ... The Lancet infectious diseases 14 (8), 706-715, 2014 | 234 | 2014 |
Current status of dengue therapeutics research and development JGH Low, EE Ooi, SG Vasudevan The Journal of infectious diseases 215 (suppl_2), S96-S102, 2017 | 221 | 2017 |
Early Dengue infection and outcome study (EDEN)-study design and preliminary findings JGH Low, EE Ooi, T Tolfvenstam, YS Leo, ML Hibberd, LC Ng, YL Lai, ... ANNALS-ACADEMY OF MEDICINE SINGAPORE 35 (11), 783, 2006 | 203 | 2006 |
Discovery and genomic characterization of a 382-nucleotide deletion in ORF7b and ORF8 during the early evolution of SARS-CoV-2 YCF Su, DE Anderson, BE Young, M Linster, F Zhu, J Jayakumar, ... MBio 11 (4), 10.1128/mbio. 01610-20, 2020 | 200 | 2020 |
Viral dynamics and immune correlates of coronavirus disease 2019 (COVID-19) severity BE Young, SWX Ong, LFP Ng, DE Anderson, WN Chia, PY Chia, LW Ang, ... Clinical Infectious Diseases 73 (9), e2932-e2942, 2021 | 199 | 2021 |
Early T cell and binding antibody responses are associated with COVID-19 RNA vaccine efficacy onset S Kalimuddin, CYL Tham, M Qui, R de Alwis, JXY Sim, JME Lim, HC Tan, ... Med 2 (6), 682-688. e4, 2021 | 196 | 2021 |
Celgosivir treatment misfolds dengue virus NS1 protein, induces cellular pro-survival genes and protects against lethal challenge mouse model APS Rathore, PN Paradkar, S Watanabe, KH Tan, C Sung, JE Connolly, ... Antiviral research 92 (3), 453-460, 2011 | 186 | 2011 |
The early clinical features of dengue in adults: challenges for early clinical diagnosis JGH Low, A Ong, LK Tan, S Chaterji, A Chow, WY Lim, KW Lee, R Chua, ... PLoS neglected tropical diseases 5 (5), e1191, 2011 | 181 | 2011 |
A single dose of self-transcribing and replicating RNA-based SARS-CoV-2 vaccine produces protective adaptive immunity in mice R De Alwis, ES Gan, S Chen, YS Leong, HC Tan, SL Zhang, C Yau, ... Molecular Therapy 29 (6), 1970-1983, 2021 | 145 | 2021 |
Critically ill COVID‐19 infected patients exhibit increased clot waveform analysis parameters consistent with hypercoagulability CW Tan, JGH Low, WH Wong, YY Chua, SL Goh, HJ Ng American journal of hematology 95 (7), E156, 2020 | 133 | 2020 |
Residual SARS-CoV-2 viral antigens detected in GI and hepatic tissues from five recovered patients with COVID-19 CCL Cheung, D Goh, X Lim, TZ Tien, JCT Lim, JN Lee, B Tan, ZEA Tay, ... Gut 71 (1), 226-229, 2022 | 132 | 2022 |